While our previous data suggest that inhibition or degradation of ER results in radiosensitisation [22], here we demonstrate that ER inhibition is not uniformly sufficient to radiosensitise AR+/ER+ breast cancer models. The gene discussed is AR; the disease is breast carcinoma.